Blockchain and Crypto Investing | The Problem with Passive Index Investing

 


In a world where digital currencies and blockchain technology are revolutionizing the financial landscape, the traditional approach of passive index investing is being critically examined. As the global market cap of cryptocurrencies surpassed $2 trillion in 2022, investors are compelled to reassess their strategies. The question arises: Is passive index investing still a viable option in the face of disruptive blockchain technology and crypto assets?

In the latest episode of Untamed Ethos, Dr. Joshua Wilson and Dr. Russell Rhoads engage with Dan Weiskopf to explore the impact of blockchain technology and crypto investing on traditional passive index investing, discussing the potential of blockchain in various industries and the role of Bitcoin futures in the institutionalization of cryptocurrency.

They discuss:

  • The distinction between investing in blockchain technology and investing in cryptocurrencies.
  • The potential of blockchain technology to revolutionize various industries, from finance to supply chain management.
  • The role of Bitcoin futures in the institutionalization of cryptocurrency.

About Joshua Wilson

Joshua Wilson is the founder of United Ethos Wealth Partners, a registered investment advisory firm. As a dedicated investment professional, he brings his wealth of knowledge and experience in finance to bear, guiding investors through the complexities of wealth management. Wilson is known for his authentic, unfiltered approach to discussing market trends and his commitment to providing meaningful insights to listeners.

About Dr. Russell Rhoads

Dr. Rhoads brings a wealth of knowledge from his extensive background in finance and business, currently serving as a Clinical Associate Professor at the Indiana University Kelley School of Business. His insights and understanding of market trends offer valuable perspectives on the current state of the stock market.

About Dan Weiskopf

Dan Weiskopf is a seasoned professional in the field of finance and investment. As the Lead ETF Strategist for Think Tank and Co-Portfolio Manager for Amplify Transformational Data Sharing ETF, he brings a wealth of knowledge and experience to the table. His insights into the evolving world of blockchain and crypto investing are sure to provide valuable perspectives for listeners.

Follow us on social media for the latest updates in B2B!

Image

Latest

Agentic AI
Agentic AI: IBM is Powering the Next Wave of Autonomous, Intelligent Decision-Making
March 14, 2025

Retail has long embraced automation, but now it’s taking a leap into a new frontier—autonomous decision-making. Enter agentic AI, a technology that doesn’t just automate tasks but makes real-time, intelligent decisions. With major retailers like Walmart integrating AI-driven fulfillment robots and brands such as Bath & Body Works rolling out personalized AI-powered shopping assistants,…

Read More
QSR connectivity
How IBM and Hughes Are Powering the Future of QSR Connectivity & Fast Food Tech
March 14, 2025

Quick service restaurants (QSRs) are under increasing pressure to enhance speed, efficiency, and customer experience—all while managing a growing network of digital systems. From AI-powered ordering kiosks to real-time kitchen automation, modern QSRs are more connected than ever. The restaurant AI market was valued at $9.68 billion in 2024, and expected to reach $49 billion…

Read More
Trade tariffs
From Asia to the World: How Dimerco is Helping Businesses Navigate New Trade Tariffs and Supply Chain Shifts
March 13, 2025

The global supply chain is once again at a crossroads, with shifting trade policies, geopolitical tensions, and economic fluctuations shaping the way goods move across the world. The looming threat of new trade tariffs on imports from Asia, combined with fluctuating shipping rates, is creating a challenging landscape for logistics professionals. With businesses re-evaluating…

Read More
sterile compounding
Sterile Compounding and Contamination Control with Abby Roth
March 11, 2025

In this episode of Exceeding Your Benchmark, host Michelle Dawn Mooney speaks with Abby Roth, founder of Pure Microbiology, about sterile compounding and contamination control. Abby shares her expertise in microbiology, sterile environments, and best practices in pharmaceutical compounding. The conversation begins with a distinction between traditional drug manufacturing and sterile compounding, highlighting the…

Read More